599 related articles for article (PubMed ID: 21212998)
1. A Cy5.5-labeled phage-displayed peptide probe for near-infrared fluorescence imaging of tumor vasculature in living mice.
Chen K; Yap LP; Park R; Hui X; Wu K; Fan D; Chen X; Conti PS
Amino Acids; 2012 Apr; 42(4):1329-37. PubMed ID: 21212998
[TBL] [Abstract][Full Text] [Related]
2. In vivo NIRF imaging-guided delivery of a novel NGR-VEGI fusion protein for targeting tumor vasculature.
Ma W; Li G; Wang J; Yang W; Zhang Y; Conti PS; Chen K
Amino Acids; 2014 Dec; 46(12):2721-32. PubMed ID: 25182731
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of four affibody-based near-infrared fluorescent probes for optical imaging of epidermal growth factor receptor positive tumors.
Qi S; Miao Z; Liu H; Xu Y; Feng Y; Cheng Z
Bioconjug Chem; 2012 Jun; 23(6):1149-56. PubMed ID: 22621238
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of 64Cu labeled GX1: a phage display peptide probe for PET imaging of tumor vasculature.
Chen K; Sun X; Niu G; Ma Y; Yap LP; Hui X; Wu K; Fan D; Conti PS; Chen X
Mol Imaging Biol; 2012 Feb; 14(1):96-105. PubMed ID: 21360213
[TBL] [Abstract][Full Text] [Related]
5. Near-infrared fluorescence imaging of CD13 receptor expression using a novel Cy5.5-labeled dimeric NGR peptide.
Li G; Xing Y; Wang J; Conti PS; Chen K
Amino Acids; 2014 Jun; 46(6):1547-56. PubMed ID: 24652439
[TBL] [Abstract][Full Text] [Related]
6. Near-infrared optical imaging of epidermal growth factor receptor in breast cancer xenografts.
Ke S; Wen X; Gurfinkel M; Charnsangavej C; Wallace S; Sevick-Muraca EM; Li C
Cancer Res; 2003 Nov; 63(22):7870-5. PubMed ID: 14633715
[TBL] [Abstract][Full Text] [Related]
7. In vivo gastric cancer targeting and imaging using novel symmetric cyanine dye-conjugated GX1 peptide probes.
Xin J; Zhang X; Liang J; Xia L; Yin J; Nie Y; Wu K; Tian J
Bioconjug Chem; 2013 Jul; 24(7):1134-43. PubMed ID: 23725355
[TBL] [Abstract][Full Text] [Related]
8. In vivo and in vitro evaluation of Cy5.5 conjugated epidermal growth factor receptor binding peptide.
Jeong MH; Kim K; Kim EM; Cheong SJ; Lee CM; Jeong HJ; Kim DW; Lim ST; Sohn MH; Chung J
Nucl Med Biol; 2012 Aug; 39(6):805-12. PubMed ID: 22421431
[TBL] [Abstract][Full Text] [Related]
9. Targeted near-infrared imaging of the erythropoietin receptor in human lung cancer xenografts.
Doleschel D; Mundigl O; Wessner A; Gremse F; Bachmann J; Rodriguez A; Klingmüller U; Jarsch M; Kiessling F; Lederle W
J Nucl Med; 2012 Feb; 53(2):304-11. PubMed ID: 22228796
[TBL] [Abstract][Full Text] [Related]
10. Near-infrared fluorescent deoxyglucose analogue for tumor optical imaging in cell culture and living mice.
Cheng Z; Levi J; Xiong Z; Gheysens O; Keren S; Chen X; Gambhir SS
Bioconjug Chem; 2006; 17(3):662-9. PubMed ID: 16704203
[TBL] [Abstract][Full Text] [Related]
11. Spectroscopically well-characterized RGD optical probe as a prerequisite for lifetime-gated tumor imaging.
Mathejczyk JE; Pauli J; Dullin C; Napp J; Tietze LF; Kessler H; Resch-Genger U; Alves F
Mol Imaging; 2011 Dec; 10(6):469-80. PubMed ID: 22201538
[TBL] [Abstract][Full Text] [Related]
12. Semiautomatic landmark-based two-dimensional-three-dimensional image fusion in living mice: correlation of near-infrared fluorescence imaging of Cy5.5-labeled antibodies with flat-panel volume computed tomography.
Dullin C; Zientkowska M; Napp J; Missbach-Guentner J; Krell HW; Müller F; Grabbe E; Tietze LF; Alves F
Mol Imaging; 2009; 8(1):2-14. PubMed ID: 19344571
[TBL] [Abstract][Full Text] [Related]
13. In vivo biodistribution and lifetime analysis of cy5.5-conjugated rituximab in mice bearing lymphoid tumor xenograft using time-domain near-infrared optical imaging.
Biffi S; Garrovo C; Macor P; Tripodo C; Zorzet S; Secco E; Tedesco F; Lorusso V
Mol Imaging; 2008; 7(6):272-82. PubMed ID: 19123997
[TBL] [Abstract][Full Text] [Related]
14. In vivo MR/optical imaging for gastrin releasing peptide receptor of prostate cancer tumor using Gd-TTDA-NP-BN-Cy5.5.
Lin YH; Dayananda K; Chen CY; Liu GC; Luo TY; Hsu HS; Wang YM
Bioorg Med Chem; 2011 Feb; 19(3):1085-96. PubMed ID: 20493715
[TBL] [Abstract][Full Text] [Related]
15. Phage peptide display.
Newton J; Deutscher SL
Handb Exp Pharmacol; 2008; (185 Pt 2):145-63. PubMed ID: 18626602
[TBL] [Abstract][Full Text] [Related]
16. 2-Nitroimidazole-tricarbocyanine conjugate as a near-infrared fluorescent probe for in vivo imaging of tumor hypoxia.
Okuda K; Okabe Y; Kadonosono T; Ueno T; Youssif BG; Kizaka-Kondoh S; Nagasawa H
Bioconjug Chem; 2012 Mar; 23(3):324-9. PubMed ID: 22335430
[TBL] [Abstract][Full Text] [Related]
17. Activatable imaging probes with amplified fluorescent signals.
Lee S; Park K; Kim K; Choi K; Kwon IC
Chem Commun (Camb); 2008 Sep; (36):4250-60. PubMed ID: 18802536
[TBL] [Abstract][Full Text] [Related]
18. Near-infrared fluorescent imaging of tumor apoptosis.
Petrovsky A; Schellenberger E; Josephson L; Weissleder R; Bogdanov A
Cancer Res; 2003 Apr; 63(8):1936-42. PubMed ID: 12702586
[TBL] [Abstract][Full Text] [Related]
19. A new atherosclerotic lesion probe based on hydrophobically modified chitosan nanoparticles functionalized by the atherosclerotic plaque targeted peptides.
Park K; Hong HY; Moon HJ; Lee BH; Kim IS; Kwon IC; Rhee K
J Control Release; 2008 Jun; 128(3):217-23. PubMed ID: 18457896
[TBL] [Abstract][Full Text] [Related]
20. An HDAC-Targeted Imaging Probe LBH589-Cy5.5 for Tumor Detection and Therapy Evaluation.
Meng Q; Liu Z; Li F; Ma J; Wang H; Huan Y; Li Z
Mol Pharm; 2015 Jul; 12(7):2469-76. PubMed ID: 26030093
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
